Robert Rottapel, MD, FRCPC

  • The Regulation of Protein Tyrosine Kinases in Hematopoiesis and Mechanism of T Cell Costimulation
    A major focus of our laboratory is the identification of signal transduction pathways controlling early events in hematopoietic and lymphopoietic development.

    One class of molecules studied in our laboratory are receptor tyrosine kinases which are highly conserved molecular 'switches' involved in developmental processes. In particular, we study the Kit and Flt3 receptor tyrosine kinases which are expressed on early hematopoietic progenitor cells.

    We have identified novel signalling molecules which regulate the function of each of these receptors and are currently interested in how these pathways participate in differentiation, cell cycle control, and cell survival responses.

    We have cloned 3BP-2 as a linker molecule which couples the Flt3 receptor tyrosine kinase to the Abl protein tyrosine kinase and induces the translocation of Abl into the nucleus. Abl participates in cell cycle control and DNA repair mechanism following DNA damage. Analysis of mice deficient in either Flt3 or Abl have shown that both are important in early B cell development. We are currently analyzing the molecular basis for the Flt3:Abl pathway during B cell development.

    A second linker type molecule identified in our laboratory is termed Socs1 (for suppressor of cytokine signalling). Socs1 binds to Kit and suppresses Kit- mediated mitogenesis while permitting signals which support cell survival, a state which favors cell differentiation to occur.

    In an attempt to understand the capacity for Socs1 to interfere with Kit dependent growth pathways, we have identified several Socs1 binding proteins. One of these currently being studied is the hematopoietic specific guanine nucleotide exchange factor, Vav. Socs1 binds to a negative regulatory region of Vav and suppresses its exchange activity. The structural basis for the regulation of Vav by Socs1 is currently under investigation.

    In order for T cells to become activated they must receive signals from both the T cell receptor and the CD28 cell surface receptor. A second area of research in the lab involves determining the biochemical pathways which are required during CD28-mediated costimulation. These pathways may be involved in regulating the amplitude of the T cell response, the longevity of this response, and the production of a memory T cell subset.

    We have identified several proximal signalling molecules which bind to the cytoplasmic tail of CD28 and are currently studying the biologic role these molecules specify in vivo during CD28 mediated costimulation using a transgenic approach.

    To contact Dr. Rottapel email his assistant Donna De Francesco.

Related Links

J Bone Miner Res. 2019 Oct 15;:
Kittaka M, Yoshimoto T, Schlosser C, Rottapel R, Kajiya M, Kurihara H, Reichenberger EJ, Ueki Y
Cancer Res. 2019 Nov 01;79(21):5536-5549
Chui MH, Doodnauth SA, Erdmann N, Tiedemann RE, Sircoulomb F, Drapkin R, Shaw P, Rottapel R
J Cell Biol. 2019 Sep 02;218(9):3077-3097
Azoitei ML, Noh J, Marston DJ, Roudot P, Marshall CB, Daugird TA, Lisanza SL, Sandí MJ, Ikura M, Sondek J, Rottapel R, Hahn KM, Danuser G
Oncotarget. 2019 Apr 26;10(31):2947-2958
Jiang DM, Fyles A, Nguyen LT, Neel BG, Sacher A, Rottapel R, Wang BX, Ohashi PS, Sridhar SS
Sci Rep. 2019 Mar 05;9(1):3590
Krzyzanowski PM, Sircoulomb F, Yousif F, Normand J, La Rose J, E Francis K, Suarez F, Beck T, McPherson JD, Stein LD, Rottapel RK
Cancer. 2019 Mar 05;:
Bast RC, Matulonis UA, Sood AK, Ahmed AA, Amobi AE, Balkwill FR, Wielgos-Bonvallet M, Bowtell DDL, Brenton JD, Brugge JS, Coleman RL, Draetta GF, Doberstein K, Drapkin RI, Eckert MA, Edwards RP, Elias KM, Ennis D, Futreal A, Gershenson DM, Greenberg RA...
Cell Rep. 2018 Jul 31;24(5):1123-1135
Dimitriou ID, Lee K, Akpan I, Lind EF, Barr VA, Ohashi PS, Samelson LE, Rottapel R
J Am Chem Soc. 2018 Mar 22;:
Gebregiworgis T, Marshall CB, Nishikawa T, Radulovich N, Sandí MJ, Fang Z, Rottapel R, Tsao MS, Ikura M
Small GTPases. 2017 Nov 30;:1-9
Fine N, Dimitriou ID, Rottapel R
Sci Signal. 2017 Oct 31;10(503):
Sandí MJ, Marshall CB, Balan M, Coyaud É, Zhou M, Monson DM, Ishiyama N, Chandrakumar AA, La Rose J, Couzens AL, Gingras AC, Raught B, Xu W, Ikura M, Morrison DK, Rottapel R

Pages


 

Professor, Department of Immunology, University of Toronto